LIFE. SCIENCE. ACORDA THERAPEUTICS

Serial Number 97608223
606

Registration Progress

Application Filed
Sep 27, 2022
Under Examination
Jul 18, 2023
Approved for Publication
May 23, 2023
Published for Opposition
May 23, 2023
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Dec 08, 2025 26 days
Revival assistance for abandoned trademark

Trademark Image

LIFE. SCIENCE. ACORDA THERAPEUTICS

Basic Information

Serial Number
97608223
Filing Date
September 27, 2022
Published for Opposition
May 23, 2023
Abandonment Date
October 8, 2025
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 8, 2025
Classes
035 041 044

Rights Holder

ACORDA THERAPEUTICS, INC.

03
Address
2 Blue Hill Plaza, 3rd Flr
Pearl River, NY 10965

Ownership History

ACORDA THERAPEUTICS, INC.

Original Applicant
03
Pearl River, NY

ACORDA THERAPEUTICS, INC.

Owner at Publication
03
Pearl River, NY

Legal Representation

Attorney
Joseph C. Guagliardo

USPTO Deadlines

Next Deadline
26 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
December 08, 2025

Application History

25 events
Date Code Type Description Documents
Oct 8, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 8, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 17, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 17, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 17, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 17, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 11, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 9, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 9, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 9, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 18, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 23, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 23, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 3, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 20, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 19, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 18, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 18, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 25, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 25, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 25, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 12, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 14, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 13, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 30, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Promoting public awareness of the need for education, research, treatment and a cure for diseases, disorders and conditions
Class 041
Entertainment and educational services, namely, providing live and online seminars, conferences and workshops concerning issues related to diseases, disorders and conditions and distributing informational course materials in connection therewith
Class 044
Providing health information; providing information and online information relating to diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations for the prevention and treatment of diseases, disorders and conditions

Additional Information

Design Mark
The mark consists of he mark "LIFE." on a first line, the mark "SCIENCE." directly thereunder on a second line, the mark "ACORDA" with a lightning bolt diagonally through the "O" on a third line with an underscore thereunder and the term "THERAPEUTICS" spaced directly under the underscore on a fourth line.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
035 041 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"SCIENCE AND THERAPEUTICS"